• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

分子克隆与一种新型 TLR9 内体的鉴定

Molecular cloning and characterization of a novel anti-TLR9 intrabody.

机构信息

Department of Gene Regulation and Differentiation, Helmholtz Centre for Infection Research, Inhoffenstraße 7, 38124 Braunschweig, Germany.

出版信息

Cell Mol Biol Lett. 2013 Sep;18(3):433-46. doi: 10.2478/s11658-013-0098-8. Epub 2013 Jul 26.

DOI:10.2478/s11658-013-0098-8
PMID:23893288
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6275677/
Abstract

Toll-like receptor 9 (TLR9) is a component of the innate immune system, which recognizes the DNA of both pathogens and hosts. Thus, it can drive autoimmune diseases. Intracellular antibodies expressed inside the ER block transitory protein functions by inhibiting the translocation of the protein from the ER to its subcellular destination. Here, we describe the construction and characterization of an anti-TLR9 ER intrabody (αT9ib). The respective single-chain Fv comprises the variable domains of the heavy and light chain of a monoclonal antibody (mAb; 5G5) towards human and murine TLR9. Co-expression of αT9ib and mouse TLR9 in HEK293 cells resulted in co-localization of both molecules with the ER marker calnexin. Co-immunoprecipitation of mouse TLR9 with αT9ib indicated that αT9ib interacts with its cognate antigen. The expression of αT9ib inhibited NF-κB-driven reporter gene activation upon CpG DNA challenge but not the activation of TLR3 or TLR4. Consequently, TLR9-driven TNFα production was inhibited in RAW264.7 macrophages upon transfection with the αT9ib expression plasmid. The αT9ib-encoding open reading frame was integrated into an adenoviral cosmid vector to produce the recombinant adenovirus (AdV)-αT9ib. Transduction with AdVαT9ib specifically inhibited TLR9-driven cellular TNFα release. These data strongly indicate that αT9ib is a very promising experimental tool to block TLR9 signaling.

摘要

Toll 样受体 9(TLR9)是先天免疫系统的一个组成部分,它可以识别病原体和宿主的 DNA。因此,它可以驱动自身免疫性疾病。细胞内抗体在 ER 内表达,通过抑制蛋白质从 ER 向其亚细胞靶位的易位来阻断瞬时蛋白质的功能。在这里,我们描述了抗 TLR9 ER 内抗体(αT9ib)的构建和表征。相应的单链 Fv 包含针对人源和鼠源 TLR9 的单克隆抗体(mAb;5G5)的重链和轻链的可变区。在 HEK293 细胞中共表达 αT9ib 和小鼠 TLR9 导致两种分子与 ER 标记物 calnexin 共定位。αT9ib 与小鼠 TLR9 的共免疫沉淀表明 αT9ib 与它的同源抗原相互作用。αT9ib 的表达抑制了 CpG DNA 挑战后 NF-κB 驱动的报告基因激活,但不激活 TLR3 或 TLR4。因此,在用 αT9ib 表达质粒转染 RAW264.7 巨噬细胞后,TLR9 驱动的 TNFα 产生被抑制。αT9ib 编码的开放阅读框被整合到腺病毒 cosmid 载体中,以产生重组腺病毒(AdV)-αT9ib。AdVαT9ib 的转导特异性抑制 TLR9 驱动的细胞 TNFα 释放。这些数据强烈表明,αT9ib 是一种非常有前途的实验工具,可以阻断 TLR9 信号。

相似文献

1
Molecular cloning and characterization of a novel anti-TLR9 intrabody.分子克隆与一种新型 TLR9 内体的鉴定
Cell Mol Biol Lett. 2013 Sep;18(3):433-46. doi: 10.2478/s11658-013-0098-8. Epub 2013 Jul 26.
2
Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation.产生抗 TLR2 内体,介导抑制巨噬细胞表面 TLR2 表达和 TLR2 驱动的细胞激活。
BMC Biotechnol. 2010 Apr 13;10:31. doi: 10.1186/1472-6750-10-31.
3
Anti-WASP intrabodies inhibit inflammatory responses induced by Toll-like receptors 3, 7, and 9, in macrophages.抗WASP细胞内抗体可抑制巨噬细胞中由Toll样受体3、7和9诱导的炎症反应。
Biochem Biophys Res Commun. 2015 Feb 27;458(1):28-33. doi: 10.1016/j.bbrc.2015.01.049. Epub 2015 Jan 26.
4
A novel role for HMGB1 in TLR9-mediated inflammatory responses to CpG-DNA.HMGB1在Toll样受体9介导的对CpG-DNA的炎症反应中的新作用。
Blood. 2007 Sep 15;110(6):1970-81. doi: 10.1182/blood-2006-09-044776. Epub 2007 Jun 4.
5
Effect of natural commensal-origin DNA on toll-like receptor 9 (TLR9) signaling cascade, chemokine IL-8 expression, and barrier integritiy of polarized intestinal epithelial cells.天然共生源 DNA 对 Toll 样受体 9(TLR9)信号级联、趋化因子 IL-8 表达和极化肠上皮细胞屏障完整性的影响。
Inflamm Bowel Dis. 2010 Mar;16(3):410-27. doi: 10.1002/ibd.21057.
6
Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.细胞内Toll样受体9(TLR9)减少使RAW264.7细胞对后续CpG寡脱氧核苷酸(ODN)刺激反应性降低。
Int Immunopharmacol. 2006 Jun;6(6):935-46. doi: 10.1016/j.intimp.2006.01.004. Epub 2006 Feb 3.
7
ER intrabody-mediated inhibition of interferon α secretion by mouse macrophages and dendritic cells.内质网内体介导的干扰素 α 在小鼠巨噬细胞和树突状细胞中的分泌抑制作用。
PLoS One. 2019 Apr 16;14(4):e0215062. doi: 10.1371/journal.pone.0215062. eCollection 2019.
8
Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.Ras通过与Toll样受体9结合并促进巨噬细胞中白细胞介素-1受体相关激酶/肿瘤坏死因子受体相关因子6复合物的形成,参与CpG寡脱氧核苷酸信号传导。
J Biol Chem. 2003 Sep 19;278(38):36334-40. doi: 10.1074/jbc.M305698200. Epub 2003 Jul 16.
9
Chicken TLR21 acts as a functional homologue to mammalian TLR9 in the recognition of CpG oligodeoxynucleotides.鸡 Toll 样受体 21(Chicken TLR21)在识别 CpG 寡脱氧核苷酸方面,发挥着与哺乳动物 Toll 样受体 9(TLR9)功能同源物的作用。
Mol Immunol. 2009 Sep;46(15):3163-70. doi: 10.1016/j.molimm.2009.06.002. Epub 2009 Jul 1.
10
HSV-1/TLR9-Mediated IFNβ and TNFα Induction Is Mal-Dependent in Macrophages.HSV-1/TLR9 介导的 IFNβ 和 TNFα 诱导在巨噬细胞中依赖 Mal。
J Innate Immun. 2020;12(5):387-398. doi: 10.1159/000504542. Epub 2019 Dec 18.

引用本文的文献

1
TLR2 and TLR9 Blockade Using Specific Intrabodies Inhibits Inflammation-Mediated Pancreatic Cancer Cell Growth.使用特异性胞内抗体阻断TLR2和TLR9可抑制炎症介导的胰腺癌细胞生长。
Antibodies (Basel). 2024 Feb 1;13(1):11. doi: 10.3390/antib13010011.
2
Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy.靶向蛋白质敲低技术的最新进展——靶向治疗的新兴模式。
Explor Target Antitumor Ther. 2023;4(6):1227-1248. doi: 10.37349/etat.2023.00194. Epub 2023 Dec 26.
3
Therapeutic Potential of Intrabodies for Cancer Immunotherapy: Current Status and Future Directions.癌症免疫治疗中胞内抗体的治疗潜力:现状与未来方向
Antibodies (Basel). 2022 Jul 18;11(3):49. doi: 10.3390/antib11030049.
4
Intrabody against prolyl hydroxylase 2 promotes angiogenesis by stabilizing hypoxia-inducible factor-1α.体内抗脯氨酰羟化酶 2 通过稳定缺氧诱导因子-1α 促进血管生成。
Sci Rep. 2019 Aug 14;9(1):11861. doi: 10.1038/s41598-019-47891-1.
5
ER intrabody-mediated inhibition of interferon α secretion by mouse macrophages and dendritic cells.内质网内体介导的干扰素 α 在小鼠巨噬细胞和树突状细胞中的分泌抑制作用。
PLoS One. 2019 Apr 16;14(4):e0215062. doi: 10.1371/journal.pone.0215062. eCollection 2019.
6
Intrabodies against the Polysialyltransferases ST8SiaII and ST8SiaIV inhibit Polysialylation of NCAM in rhabdomyosarcoma tumor cells.针对多唾液酸转移酶ST8SiaII和ST8SiaIV的细胞内抗体可抑制横纹肌肉瘤肿瘤细胞中神经细胞黏附分子(NCAM)的多唾液酸化。
BMC Biotechnol. 2017 May 12;17(1):42. doi: 10.1186/s12896-017-0360-7.
7
Specific in vivo knockdown of protein function by intrabodies.通过胞内抗体在体内特异性敲低蛋白质功能。
MAbs. 2015;7(6):1010-35. doi: 10.1080/19420862.2015.1076601. Epub 2015 Aug 7.
8
Intracellular Acidosis Promotes Mitochondrial Apoptosis Pathway: Role of EMMPRIN Down-regulation via Specific Single-chain Fv Intrabody.细胞内酸中毒促进线粒体凋亡途径:通过特异性单链Fv抗体库下调细胞外基质金属蛋白酶诱导因子的作用
J Cancer. 2015 Jan 20;6(3):276-86. doi: 10.7150/jca.10879. eCollection 2015.

本文引用的文献

1
UNC93B1 mediates differential trafficking of endosomal TLRs.UNC93B1介导内体Toll样受体的差异运输。
Elife. 2013 Feb 19;2:e00291. doi: 10.7554/eLife.00291.
2
TLR7 and TLR9 in SLE: when sensing self goes wrong.TLR7 和 TLR9 在系统性红斑狼疮中的作用:自身识别出现差错时。
Immunol Res. 2012 Sep;53(1-3):58-77. doi: 10.1007/s12026-012-8270-1.
3
Functional inhibition of transitory proteins by intrabody-mediated retention in the endoplasmatic reticulum.通过内体介导的内质网滞留来抑制瞬态蛋白的功能。
Methods. 2012 Mar;56(3):338-50. doi: 10.1016/j.ymeth.2011.10.008. Epub 2011 Oct 20.
4
Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.疟原虫药物和咪唑喹啉对内体 TLR 抑制的作用机制。
J Immunol. 2011 Apr 15;186(8):4794-804. doi: 10.4049/jimmunol.1000702. Epub 2011 Mar 11.
5
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.模式识别受体在天然免疫中的作用:Toll 样受体更新。
Nat Immunol. 2010 May;11(5):373-84. doi: 10.1038/ni.1863. Epub 2010 Apr 20.
6
Generation of anti-TLR2 intrabody mediating inhibition of macrophage surface TLR2 expression and TLR2-driven cell activation.产生抗 TLR2 内体,介导抑制巨噬细胞表面 TLR2 表达和 TLR2 驱动的细胞激活。
BMC Biotechnol. 2010 Apr 13;10:31. doi: 10.1186/1472-6750-10-31.
7
Targeting Toll-like receptors: emerging therapeutics?靶向 Toll 样受体:新兴治疗方法?
Nat Rev Drug Discov. 2010 Apr;9(4):293-307. doi: 10.1038/nrd3203.
8
Endosomal Toll-like receptors in autoimmunity: mechanisms for clinical diversity.自身免疫中的内体 Toll 样受体:临床多样性的机制
Therapy. 2009 May 1;6(3):433-442. doi: 10.2217/thy.09.2.
9
Treatment with a toll-like receptor inhibitory GpG oligonucleotide delays and attenuates lupus nephritis in NZB/W mice.TLR 抑制性 GpG 寡核苷酸治疗可延迟和减轻 NZB/W 小鼠狼疮肾炎。
Autoimmunity. 2010 Mar;43(2):140-55. doi: 10.3109/08916930903229239.
10
TLRs and chronic inflammation.TLRs 与慢性炎症。
Int J Biochem Cell Biol. 2010 Apr;42(4):495-505. doi: 10.1016/j.biocel.2009.10.010. Epub 2009 Oct 17.